Back to Search
KIMBERLY KEITH, M.D.
M.D.
Emergency Medicine Physician
NPI: 1619961836Individual
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
9601644(NC)
Research & Publications (20)
Functional characterization of OXA-57, a class D beta-lactamase from Burkholderia pseudomallei.
PMID 15793160·Antimicrob Agents Chemother·2005
8-other
Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia.
PMID 19332803·Microbiology (Reading)·2009
7-preclinical
Report of the International Conference on Risk Communication Strategies for BSL-4 laboratories, Tokyo, October 3-5, 2007.
PMID 19635008·Biosecur Bioterror·2009
8-other
Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections.
PMID 19029322·Antimicrob Agents Chemother·2009
7-preclinical
Treatment of human immunodeficiency virus-associated facial lipodystrophy syndrome with dermafat graft transfer to the nasolabial fold areas: a case report and review of the literature.
PMID 18718403·J Oral Maxillofac Surg·2008
5-case
Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine.
PMID 18321387·Virol J·2008
7-preclinical
Pseudomonas aeruginosa infection of the auricular cartilage caused by "high ear piercing": a case report and review of the literature.
PMID 18280391·J Oral Maxillofac Surg·2008
5-case
Isolation and characterization of cidofovir resistant vaccinia viruses.
PMID 18479513·Virol J·2008
7-preclinical
N-(3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6- ethenocycloprop[f]isoindol-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors.
PMID 17335190·J Med Chem·2007
7-preclinical
Synthesis and antiviral evaluation of alkoxyalkyl-phosphate conjugates of cidofovir and adefovir.
PMID 17367874·Antiviral Res·2007
4-observational
Synergistic efficacy of the combination of ST-246 with CMX001 against orthopoxviruses.
PMID 17724153·Antimicrob Agents Chemother·2007
7-preclinical
Effect of oral treatment with hexadecyloxypropyl-[(S)-9-(3-hydroxy-2- phosphonylmethoxypropyl)adenine] [(S)-HPMPA] or octadecyloxyethyl-(S)-HPMPA on cowpox or vaccinia virus infections in mice.
PMID 17846137·Antimicrob Agents Chemother·2007
7-preclinical
Burkholderia cenocepacia C5424 produces a pigment with antioxidant properties using a homogentisate intermediate.
PMID 17933889·J Bacteriol·2007
7-preclinical
Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase.
PMID 17325220·Antimicrob Agents Chemother·2007
8-other
Characterization of SodC, a periplasmic superoxide dismutase from Burkholderia cenocepacia.
PMID 17325048·Infect Immun·2007
7-preclinical
Antiviral activities of novel 5-phosphono-pent-2-en-1-yl nucleosides and their alkoxyalkyl phosphonoesters.
PMID 17130297·Antimicrob Agents Chemother·2007
8-other
Mercury transport and bioaccumulation in riverbank communities of the Alvarado Lagoon System, Veracruz State, Mexico.
PMID 17850849·Sci Total Environ·2007
7-preclinical
Efficacy of delayed treatment with ST-246 given orally against systemic orthopoxvirus infections in mice.
PMID 17116683·Antimicrob Agents Chemother·2007
7-preclinical
Toward orthopoxvirus countermeasures: a novel heteromorphic nucleoside of unusual structure.
PMID 16821766·J Med Chem·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2808 S CROATAN HWY, STE C-1
NAGS HEAD, NC 27959 - Phone
- (252) 449-5500
Quick Facts
- NPI
- 1619961836
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile